PERKINS CAPITAL MANAGEMENT INC
13F Reported Value
ⓘ$133.0M
Holdings
79
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
PERKINS CAPITAL MANAGEMENT INC disclosed 79 positions worth $133.0M in its Form 13F-HR for Q2 2026, led by $NTRA (Natera, Inc.) at 8.3% of the equity portfolio, followed by $LLY and $AMD. During the quarter the fund opened 4 new positions and exited 11 — including a new stake in $CREX and a full exit from $INGN. The portfolio is most concentrated in Healthcare (56.1% of disclosed assets). All figures are sourced directly from PERKINS CAPITAL MANAGEMENT INC’s Form 13F-HR filing with the SEC under CIK 884300.
AI Fund Analysis
ConcentratingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- 53.5#1,383
Quality
$11.0M40,605 sh - 87.5#2
Quality
$10.4M8,680 sh - 79.8#32
Quality
$8.1M13,904 sh - 33.8
Quality
$7.3M867,580 sh - 40.8
Quality
$6.8M147,842 sh - 19.4
Quality
$6.5M515,011 sh - —
Quality
$5.1M257,621 sh - 73.8
Quality
$5.1M9,700 sh - 47.7
Quality
$4.9M308,725 sh - 79.8
Quality
$4.2M11,173 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 Natera, Inc.$NTRA | 53.5#1,383 | $11.0M | 40,605 |
 ELI LILLY & Co$LLY | 87.5#2 | $10.4M | 8,680 |
 ADVANCED MICRO DEVICES INC$AMD | 79.8#32 | $8.1M | 13,904 |
 Butterfly Network, Inc.$BFLY | 33.8 | $7.3M | 867,580 |
 Axogen, Inc.$AXGN | 40.8 | $6.8M | 147,842 |
 Inuvo, Inc.$INUV | 19.4 | $6.5M | 515,011 |
 QUICKLOGIC Corp$QUIK | — | $5.1M | 257,621 |
 IDEXX LABORATORIES INC /DE$IDXX | 73.8 | $5.1M | 9,700 |
 Backblaze, Inc.$BLZE | 47.7 | $4.9M | 308,725 |
 MICROSOFT CORP$MSFT | 79.8 | $4.2M | 11,173 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of PERKINS CAPITAL MANAGEMENT INC's 79 positions.
Showing top 10 of 79 holdings.
Sector Allocation
Healthcare
$74.6M
Technology
$48.8M
Communication Services
$2.9M
Financials
$2.8M
Materials
$1.2M
Consumer Discretionary
$968,614
Energy
$803,031
Industrials
$497,644
Full Holdings — PERKINS CAPITAL MANAGEMENT INC (Q2 2026)
All 79 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $NTRA | Natera, Inc. | $11.0M | 8.3% | -8% | 53.5 |
| 2 | $LLY | ELI LILLY & Co | $10.4M | 7.8% | -2% | 87.5 |
| 3 | $AMD | ADVANCED MICRO DEVICES INC | $8.1M | 6.1% | -10% | 79.8 |
| 4 | $BFLY | Butterfly Network, Inc. | $7.3M | 5.5% | -7% | 33.8 |
| 5 | $AXGN | Axogen, Inc. | $6.8M | 5.1% | -12% | 40.8 |
| 6 | $INUV | Inuvo, Inc. | $6.5M | 4.9% | -12% | 19.4 |
| 7 | $QUIK | QUICKLOGIC Corp | $5.1M | 3.9% | -16% | — |
| 8 | $IDXX | IDEXX LABORATORIES INC /DE | $5.1M | 3.8% | +0% | 73.8 |
| 9 | $BLZE | Backblaze, Inc. | $4.9M | 3.7% | -9% | 47.7 |
| 10 | $MSFT | MICROSOFT CORP | $4.2M | 3.1% | -2% | 79.8 |
| 11 |  $VCYT | VERACYTE, INC. | $3.5M | 2.6% | -20% | 68.6 |
| 12 |  $OOMA | OOMA INC | $3.4M | 2.6% | -2% | 57.2 |
| 13 |  $PSNL | Personalis, Inc. | $3.2M | 2.4% | +0% | 11.3 |
| 14 |  $CYRX | Cryoport, Inc. | $3.1M | 2.4% | -2% | 29 |
| 15 |  $CIEN | CIENA CORP | $3.1M | 2.3% | +0% | 72.9 |
| 16 |  $LMAT | LEMAITRE VASCULAR INC | $2.4M | 1.8% | -2% | 66 |
| 17 |  $MGNI | MAGNITE, INC. | $1.9M | 1.4% | -17% | 66.1 |
| 18 |  $ABT | ABBOTT LABORATORIES | $1.8M | 1.4% | -2% | 65.5 |
| 19 |  $USIO | Usio, Inc. | $1.7M | 1.3% | -0% | 29.9 |
| 20 |  $ONDS | Ondas Inc. | $1.7M | 1.3% | -0% | 56.4 |
| 21 |  $NEO | NEOGENOMICS INC | $1.6M | 1.2% | -17% | 34.3 |
| 22 |  $PERI | Perion Network Ltd. | $1.6M | 1.2% | +5% | — |
| 23 |  $NEOG | NEOGEN CORP | $1.6M | 1.2% | -0% | 44.9 |
| 24 |  $CXDO | Crexendo, Inc. | $1.6M | 1.2% | +9% | 58.8 |
| 25 |  $ATEC | Alphatec Holdings, Inc. | $1.5M | 1.1% | +2% | 43.3 |
| 26 |  $ABBV | AbbVie Inc. | $1.3M | 1.0% | -1% | 72.6 |
| 27 |  $CREX | CREATIVE REALITIES, INC. | $1.2M | 0.9% | NEW | 31.6 |
| 28 |  $LUCD | Lucid Diagnostics Inc. | $1.2M | 0.9% | -0% | — |
| 29 |  $CDXS | CODEXIS, INC. | $1.2M | 0.9% | -0% | 28.9 |
| 30 |  $ZETA | Zeta Global Holdings Corp. | $1.1M | 0.8% | +0% | 63.4 |
| 31 |  $TLSI | TriSalus Life Sciences, Inc. | $1.1M | 0.8% | +2% | 29.7 |
| 32 |  $TELA | TELA Bio, Inc. | $1.0M | 0.8% | -3% | 25.2 |
| 33 |  $BDSX | BIODESIX INC | $1.0M | 0.8% | -0% | 35 |
| 34 |  $SPAI | Safe Pro Group Inc. | $998,065 | 0.8% | -0% | — |
| 35 |  $MRK | Merck & Co., Inc. | $963,750 | 0.7% | -3% | 59.9 |
| 36 |  $GILD | GILEAD SCIENCES, INC. | $911,669 | 0.7% | +0% | 57.4 |
| 37 |  $VTRS | Viatris Inc | $854,932 | 0.6% | -2% | 45.4 |
| 38 |  $PFE | PFIZER INC | $812,917 | 0.6% | -6% | 62 |
| 39 |  $BKSY | BlackSky Technology Inc. | $802,700 | 0.6% | +0% | 28.3 |
| 40 |  $AAPL | Apple Inc. | $766,804 | 0.6% | +0% | 76.4 |
| 41 |  $PROF | Profound Medical Corp. | $759,962 | 0.6% | +0% | — |
| 42 |  $USB | US BANCORP \DE\ | $745,940 | 0.6% | -2% | 65.3 |
| 43 |  $NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | $743,754 | 0.6% | -83% | — |
| 44 |  $VIDA | VIDA Global Inc. | $700,000 | 0.5% | NEW | — |
| 45 |  $TGT | TARGET CORP | $620,397 | 0.5% | -3% | 60.7 |
| 46 |  $OWLT | Owlet, Inc. | $611,281 | 0.5% | +0% | 35.8 |
| 47 |  $ELWT | Elauwit Connection, Inc. | $597,935 | 0.5% | +0% | 14.4 |
| 48 |  $MDXH | MDxHealth SA | $579,722 | 0.4% | -4% | — |
| 49 |  $STX | Seagate Technology Holdings plc | $506,625 | 0.4% | -5% | — |
| 50 |  $ATRC | AtriCure, Inc. | $489,650 | 0.4% | -33% | 59 |
| 51 |  $COP | CONOCOPHILLIPS | $483,414 | 0.4% | -4% | 70.2 |
| 52 |  $NXPI | NXP Semiconductors N.V. | $477,751 | 0.4% | -6% | — |
| 53 |  $LFVN | Lifevantage Corp | $470,858 | 0.3% | +0% | 40.6 |
| 54 |  $CELC | Celcuity Inc. | $470,790 | 0.3% | -17% | — |
| 55 |  $GIS | GENERAL MILLS INC | $434,350 | 0.3% | -6% | 50.7 |
| 56 |  $SKYT | SkyWater Technology, LLC | $414,358 | 0.3% | -55% | 59 |
| 57 |  $BMY | BRISTOL MYERS SQUIBB CO | $413,712 | 0.3% | -3% | 70.4 |
| 58 |  $DCI | DONALDSON Co INC | $412,942 | 0.3% | +0% | 60.5 |
| 59 |  $QTI | QT IMAGING HOLDINGS, INC. | $407,000 | 0.3% | NEW | — |
| 60 |  $VZ | VERIZON COMMUNICATIONS INC | $385,633 | 0.3% | +0% | 65.8 |
| 61 |  $CSTL | CASTLE BIOSCIENCES INC | $384,939 | 0.3% | +5% | 40.7 |
| 62 |  $ELUT | ELUTIA INC. | $379,934 | 0.3% | -8% | — |
| 63 |  $FAST | FASTENAL CO | $348,217 | 0.3% | +0% | 66.9 |
| 64 |  $T | AT&T INC. | $331,034 | 0.3% | +0% | 65.7 |
| 65 |  $BP | BP PLC | $319,617 | 0.2% | -6% | — |
| 66 |  $JNJ | JOHNSON & JOHNSON | $304,764 | 0.2% | +0% | 69 |
| 67 |  $BLNE | Beeline Holdings, Inc. | $290,360 | 0.2% | -3% | — |
| 68 |  $MRNA | Moderna, Inc. | $280,120 | 0.2% | +0% | 21.2 |
| 69 |  $XGN | EXAGEN INC. | $264,101 | 0.2% | -21% | 27.3 |
| 70 |  $APYX | Apyx Medical Corp | $188,580 | 0.1% | +0% | 27.6 |
| 71 |  $AIRG | AIRGAIN INC | $138,600 | 0.1% | +0% | 18.2 |
| 72 |  $PBYI | PUMA BIOTECHNOLOGY, INC. | $108,674 | 0.1% | +7% | 53.8 |
| 73 |  $OPRX | OptimizeRx Corp | $84,702 | 0.1% | -7% | 57.4 |
| 74 |  $IRIX | IRIDEX CORP | $81,066 | 0.1% | +28% | 25 |
| 75 |  $CATX | Perspective Therapeutics, Inc. | $62,062 | 0.1% | NEW | — |
| 76 |  $SOPH | SOPHiA GENETICS SA | $60,585 | 0.1% | +0% | — |
| 77 |  $LUNG | Pulmonx Corp | $51,350 | 0.0% | -4% | 23.4 |
| 78 |  $DYAI | DYADIC INTERNATIONAL INC | $43,053 | 0.0% | +0% | — |
| 79 |  $ARAY | ACCURAY INC | $5,156 | 0.0% | -62% | 23 |
New Positions (4)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for PERKINS CAPITAL MANAGEMENT INC including:
Track PERKINS CAPITAL MANAGEMENT INC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for PERKINS CAPITAL MANAGEMENT INC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: PERKINS CAPITAL MANAGEMENT INC
13F Pro is an AI hedge fund tracker and stock research platform. For PERKINS CAPITAL MANAGEMENT INC (SEC CIK: 884300), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in PERKINS CAPITAL MANAGEMENT INC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.